Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled sitespecific delivery of acidic anti-inflammatory active ingredient
- 1 September 2005
- journal article
- research article
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 6 (3) , E536-E542
Abstract
The purpose of the investigation was to evaluate the potential of polyamidoamine (PAMAM) dendrimer as nanoscale drug delivery units for controlled release of water insoluble and acidic anti-inflammatory drug. Flurbiprofen (FB) was selected as a model acidic anti-inflammatory drug. The aqueous solutions of 4.0 generation (G) PAMAM dendrimer in different concentrations were prepared and used further for solubilizing FB. Formation of dendrimer complex was characterized by Fourier transform infrared spectroscopy. The effect of pH on the solubility of FB in dendrimer was evaluated. Dendrimer formulations were further evaluated for in vitro release study and hemolytic toxicity. Pharmacokinetic and biodistribution were studied in male albino rats. Efficacy of dendrimer formulation was tested by carrageenan induced paw edema model. It was observed that the loaded drug displayed initial rapid release (more than 40% till 3rd hour) followed by rather slow release. Pharmacodynamic study revealed 75% inhibition at 4th hour that was maintained above 50% till 8th hour. The mean residence time (MRT) and terminal half-life (THF) of the dendritic formulation increased by 2-fold and 3-fold, respectively, compared with free drug. Hence, with dendritic system the drug is retained for longer duration in the biosystem with 5-fold greater distribution. It may be concluded that the drug-loaded dendrimers not only enhanced the solubility but also controlled the delivery of the bioactive with localized action at the site of inflammation.Keywords
This publication has 16 references indexed in Scilit:
- Solubility Enhancement of Indomethacin with Poly(amidoamine) Dendrimers and Targeting to Inflammatory Regions of Arthritic RatsJournal of Drug Targeting, 2004
- Phase Structures of a Hydrated Anionic Phospholipid Composition Containing Cationic Dendrimers and Pegylated LipidsLangmuir, 2004
- Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacinJournal of Controlled Release, 2003
- Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymersInternational Journal of Pharmaceutics, 2003
- A PEGylated dendritic nanoparticulate carrier of fluorouracilInternational Journal of Pharmaceutics, 2003
- Interactions between PAMAM dendrimers and bovine serum albuminBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2003
- Dendrimers as potential drug carriers; encapsulation of acidic hydrophobes within water soluble PAMAM derivativesTetrahedron, 2003
- Dendritic polymer macromolecular carriers for drug deliveryCurrent Opinion in Chemical Biology, 2002
- Polyamidoamine Starburst® dendrimers as solubility enhancersInternational Journal of Pharmaceutics, 2000
- About Dendrimers: Structure, Physical Properties, and ApplicationsChemical Reviews, 1999